Allon Appoints Vice-President of Business Development Allon Therapeutics Inc. (TSX: NPC), The Neuro Protection CompanyTM, announced today the appointment of Dr. Annette Kleiser as Vice-President of Business Development for the Company. Dr. Kleiser, an internationally recognised pharmaceutical executive joins Allon from Epigenomics in Seattle where she held a similar position and prior to that was with Amgen, a global pharmaceutical company. Simon Fraser University Welcomes Dr. Norbert H. Haunerland as Associate Vice-President, Research Simon Fraser University's Vice-President, Research, Dr. B. Mario Pinto, is pleased to announce the addition of Dr. Norbert H. Haunerland as Associate Vice-President, Research, effective September 1st, 2007.

send this to a friend unsubscrive © LifeSciences British Columbia. All rights reserved.

Suite 900 - 1188 West Georgia St. Vancouver, BC V6E 4A2